Panacea Life Sciences Holdings, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -83.9% | -82.6% | -125.0% |
| FY2020 | -78.0% | -74.3% | -16.7% |
| FY2021 | -67.3% | -67.3% | -20.1% |
| FY2022 | 426.3% | 426.3% | -46.9% |
| FY2023 | 96.7% | 96.7% | -44.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2019 | -83.9% | -82.6% | -125.0% |
| FY2020 | -78.0% | -74.3% | -16.7% |
| FY2021 | -67.3% | -67.3% | -20.1% |
| FY2022 | 426.3% | 426.3% | -46.9% |
| FY2023 | 96.7% | 96.7% | -44.6% |